Dalriada Therapeutics
Mississauga
About Dalriada Therapeutics
Dalriada is a small molecule drug discovery company supporting global innovators through its TURN-KEY model, where R&D is perfectly aligned with business and IP.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $25.0K
- Funding stage: Seed
- Last round: Grant (Nov 2020)
- Website: dalriadatx.com
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/dalriada-therapeutics-104550 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.